Peng Cai

Dr. Peng Cai


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 November 2016 in Cardiovascular Diabetology
Verified
Journal Article
Open access
PDF file
JMJia Min
Jia Min
ZWZhong Weitian
Zhong Weitian
PCPeng Cai
Peng Cai
PYPeng Yan
Peng Yan
ZBZhang Bo
Zhang Bo
XWXukai Wang
Xukai Wang
Hyperinsulinemia and insulin resistance have been recently recognized as an important cause of atherosclerosis. Clinical studies have also found that expression of the estrogen receptor is closely related to the incidence of atherosclerosis. This study investigate the effects of insulin and estrogen receptor α (ER-α) in atherosclerosis. Double knockout ApoE/Lepr mice were given intraperitoneal injections of insulin, and their aortae were harvested for hematoxylin-eosin staining and immunohistochemical analysis. In addition, vascular smooth muscle cells (VSMCs) were treated with insulin or infected with a lentivirus encoding exogenous ER-α, and changes in gene expression were detected by real-time polymerase chain reaction and western blotting. The methylation levels of the ER-α gene were tested using bisulfite sequencing PCR, and flow cytometry and EdU assay were used to measure VSMCs proliferation. Our results showed that insulin can induce the formation of atherosclerosis. Gene expression analysis revealed that insulin promotes the expression of DNA methyltransferases and inhibits ER-α expression, while 5-aza-2′-deoxycytidine can inhibit this effect of insulin. Bisulfite sequencing PCR analysis showed that methylation of the ER-α second exon region increased in VSMCs treated with insulin. The results also showed that ER-α can inhibit VSMCs proliferation. Our data suggest that insulin promotes the expression of DNA methyltransferases, induces methylation of ER-α second exon region and decreases the expression of ER-α, thereby interfering with estrogen regulation of VSMCs proliferation, resulting in atherosclerosis.

29 May 2026 in Medicine
Verified
Journal Article
Open access
MGMengran Guo
Mengran Guo
CLChao Liu
Chao Liu
DLDan Lv
Dan Lv
QLQingshu Lin
Qingshu Lin
AZAli Zhang
Ali Zhang
PCPeng Cai
Peng Cai
This study aimed to investigate the associations between thyroid hormones, metabolic syndrome (MetS), and coronary artery stenosis (CAS) in euthyroid patients, given the insufficient evidence on concurrent evaluation of these endpoints. In this cross-sectional study, demographic data, biochemical parameters, and coronary angiography were collected. The Gensini score was quantified to determine CAS severity. Participants were assigned to non-MetS and MetS groups, and further categorized into non-CAS, CAS I (stenosis < 50%), and CAS II (stenosis ≥ 50%) subgroups. The association between thyroid hormones, MetS, and CAS was analyzed. This study was approved by the Ethics Committee of the Army Medical Center of PLA. A total of 947 euthyroid adults were enrolled in the present study. Notably, free triiodothyronine (FT3) and the FT3/free thyroxine (FT4) ratio were significantly higher in the MetS group compared with the non-MetS group (all P < .05). In contrast, FT3, total triiodothyronine, and the FT3/FT4 ratio were markedly lower in the CAS II group than in the non-CAS group (all P < .05). Spearman correlation analysis in CAS patients showed that FT3, total triiodothyronine, and the FT3/FT4 ratio were negatively correlated with the Gensini score, and positively correlated with diastolic blood pressure, body mass index, and triglycerides ( P < .05). After adjustment for potential confounders, multivariate linear regression analysis showed that FT3 remained significantly and linearly negatively correlated with the Gensini score ( P < .001). In euthyroid individuals, thyroid hormones, particularly FT3, have inconsistent correlations with MetS and CAS, reflecting the complexity of thyroid hormone physiology.